Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies.
J Neurol Neurosurg Psychiatry
; 94(4): 290-299, 2023 04.
Article
em En
| MEDLINE
| ID: mdl-36522154
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
COVID-19
/
Esclerose Múltipla
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article